Advertisement
U.S. markets closed

ICL Group Ltd (ICL)

NYSE - NYSE Delayed Price. Currency in USD
5.38+0.02 (+0.37%)
At close: 04:02PM EDT
5.37 -0.01 (-0.19%)
After hours: 06:40PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close5.36
Open5.34
Bid5.19 x 2200
Ask5.37 x 3100
Day's Range5.29 - 5.39
52 Week Range4.30 - 6.91
Volume1,084,522
Avg. Volume915,596
Market Cap6.938B
Beta (5Y Monthly)0.58
PE Ratio (TTM)10.76
EPS (TTM)0.50
Earnings DateN/A
Forward Dividend & Yield0.19 (3.57%)
Ex-Dividend DateMar 14, 2024
1y Target Est5.31
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
99% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ICL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ICL Group Ltd.
    NTR: What does Argus have to say about NTR?NUTRIEN LTD has an Investment Rating of HOLD; a target price of $56.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • Business Wire

    ICL Files 2023 Annual Report on Form 20-F

    TEL AVIV, Israel, March 14, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint.

  • Business Wire

    ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition

    TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately $30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL’s product offerings and positioning the company for further expansions into new and adjacent end-markets.

  • Business Wire

    ICL Reports Fourth Quarter and Full Year 2023 Results

    TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earni